{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:38:10Z","timestamp":1789749490928,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T00:00:00Z","timestamp":1497657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s40257-017-0308-7","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T04:58:54Z","timestamp":1497675534000},"page":"67-77","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Drug-Induced Pyoderma Gangrenosum: A Review"],"prefix":"10.1007","volume":"19","author":[{"given":"Jane Y.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars E.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afkham","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,17]]},"reference":[{"issue":"2","key":"308_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-0560.2003.00024.x","volume":"30","author":"AN Crowson","year":"2003","unstructured":"Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum: a review. J Cutan Pathol. 2003;30(2):97\u2013107.","journal-title":"J Cutan Pathol"},{"key":"308_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15226","author":"AV Marzano","year":"2016","unstructured":"Marzano AV, Damiani G, Ceccherini I, et al. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol. 2016. doi: 10.1111\/bjd.15226 .","journal-title":"Br J Dermatol"},{"issue":"1","key":"308_CR3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cei.12394","volume":"178","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Fanoni D, Antiga E, et al. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet\u2019s syndrome. Clin Exp Immunol. 2014;178(1):48\u201356.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"308_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-2-19","volume":"15","author":"U Wollina","year":"2007","unstructured":"Wollina U. Pyoderma gangrenosum\u2014a review. Orphanet J Rare Dis. 2007;15(2):19.","journal-title":"Orphanet J Rare Dis."},{"key":"308_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15193","author":"BC Wu","year":"2016","unstructured":"Wu BC, Patel ED, Ortega-Loayza AG. Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum. Br J Dermatol. 2016. doi: 10.1111\/bjd.15193 .","journal-title":"Br J Dermatol"},{"issue":"1","key":"308_CR6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0151-9638(05)79191-2","volume":"132","author":"A Boulenger-Vazel","year":"2005","unstructured":"Boulenger-Vazel A, Kupfer-Bessaguet I, Gouedard C, et al. Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies). Ann Dermatol Venereol. 2005;132(1):27\u201331.","journal-title":"Ann Dermatol Venereol"},{"issue":"9","key":"308_CR7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0001-7310(08)76179-9","volume":"99","author":"E Roche","year":"2008","unstructured":"Roche E, Mart\u00ednez-Mench\u00f3n T, S\u00e1nchez-Carazo JL, et al. Two cases of eruptive pyoderma gangrenosum associated with cocaine use. Actas Dermosifiliogr. 2008;99(9):727\u201330.","journal-title":"Actas Dermosifiliogr."},{"issue":"9","key":"308_CR8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/MEG.0b013e32816e070b","volume":"19","author":"A Yurci","year":"2007","unstructured":"Yurci A, Guven K, Torun E, et al. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C. Eur J Gastroenterol Hepatol. 2007;19(9):811\u20135.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"308_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"308_CR10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archderm.1983.01650340018012","volume":"119","author":"JH Exner","year":"1983","unstructured":"Exner JH, Dahod S, Pochi PE. Pyogenic granuloma-like acne lesions during isotretinoin therapy. Arch Dermatol. 1983;119(10):808\u201311.","journal-title":"Arch Dermatol"},{"issue":"6","key":"308_CR11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1078155214541975","volume":"21","author":"CA Dasanu","year":"2015","unstructured":"Dasanu CA, Bockorny B, Alexandrescu DT. Pyoderma gangrenosum due to lenalidomide use for multiple myeloma. J Oncol Pharm Pract. 2015;21(6):471\u20133.","journal-title":"J Oncol Pharm Pract."},{"issue":"4","key":"308_CR12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2133.1997.tb02168.x","volume":"136","author":"HB Gangaram","year":"1997","unstructured":"Gangaram HB, Tan LP, Gan AT, et al. Pyoderma gangrenosum following treatment with isotretinoin. Br J Dermatol. 1997;136(4):636\u20137.","journal-title":"Br J Dermatol"},{"issue":"8","key":"308_CR13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1365-4632.2006.02749.x","volume":"45","author":"R Sagara","year":"2006","unstructured":"Sagara R, Kitami A, Nakada T, Iijima M. Adverse reactions to gefitinib (Iressa): revealing sycosis- and pyoderma gangrenosum-like lesions. Int J Dermatol. 2006;45(8):1002\u20133.","journal-title":"Int J Dermatol"},{"issue":"4","key":"308_CR14","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4161\/hv.27699","volume":"10","author":"M Sobieszcza\u0144ska","year":"2014","unstructured":"Sobieszcza\u0144ska M, Tubek S, Kura I. Pyoderma gangrenosum-like skin changes after subcutaneous administration of low molecular weight heparin. Hum Vaccin Immunother. 2014;10(4):968\u20139.","journal-title":"Hum Vaccin Immunother."},{"issue":"11","key":"308_CR15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-4632.2004.02128.x","volume":"43","author":"WP Su","year":"2004","unstructured":"Su WP, Davis MD, Weenig RH, et al. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004;43(11):790\u2013800.","journal-title":"Int J Dermatol"},{"issue":"11","key":"308_CR16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/2047-783X-16-11-491","volume":"16","author":"S Akanay-Diesel","year":"2011","unstructured":"Akanay-Diesel S, Hoff NP, K\u00fcrle S, et al. Sunitinib induced pyoderma gangrenosum-like ulcerations. Eur J Med Res. 2011;16(11):491\u20134.","journal-title":"Eur J Med Res."},{"issue":"8","key":"308_CR17","first-page":"34","volume":"3","author":"SM Dean","year":"2010","unstructured":"Dean SM, Zirwas M. A second case of sunitinib-associated pyoderma gangrenosum. J Clin Aesthet Dermatol. 2010;3(8):34\u20135.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"2","key":"308_CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jdcr.2016.01.003","volume":"2","author":"JM Levy","year":"2016","unstructured":"Levy JM, Richler D, Mahmood MN, Brassard A. Pyoderma gangrenosum associated with alitretinoin therapy. JAAD Case Rep. 2016;2(2):135\u20137.","journal-title":"JAAD Case Rep."},{"issue":"12","key":"308_CR19","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1503\/cmaj.140122","volume":"186","author":"IV Litvinov","year":"2014","unstructured":"Litvinov IV, Sasseville D. Pyoderma gangrenosum triggered by red tattoo dye. CMAJ. 2014;186(12):935.","journal-title":"CMAJ"},{"issue":"8","key":"308_CR20","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/ced.12207","volume":"38","author":"D Jim\u00e9nez-Gallo","year":"2013","unstructured":"Jim\u00e9nez-Gallo D, Albarr\u00e1n-Planelles C, Linares-Barrios M, et al. Pyoderma gangrenosum and Wegener granulomatosis-like syndrome induced by cocaine. Clin Exp Dermatol. 2013;38(8):878\u201382.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"308_CR21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/0022-3859.118059","volume":"59","author":"DJ Pinato","year":"2013","unstructured":"Pinato DJ, Sharma R. Imatinib induced pyoderma gangrenosum. J Postgrad Med. 2013;59(3):244\u20135.","journal-title":"J Postgrad Med."},{"issue":"5","key":"308_CR22","first-page":"447","volume":"11","author":"L Kowalzick","year":"2013","unstructured":"Kowalzick L, Bertolini J, Baumann C, et al. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis. J Dtsch Dermatol Ges. 2013;11(5):447\u20139.","journal-title":"J Dtsch Dermatol Ges."},{"issue":"6","key":"308_CR23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archderm.144.6.817","volume":"144","author":"M Stichenwirth","year":"2008","unstructured":"Stichenwirth M, Riedl E, Pehamberger H, Tappeiner G. Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon? Arch Dermatol. 2008;144(6):817\u20138.","journal-title":"Arch Dermatol"},{"issue":"5\u20136","key":"308_CR24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/10428199709050901","volume":"26","author":"C Lewerin","year":"1997","unstructured":"Lewerin C, Mobacken H, Nilsson-Ehle H, Swolin B. Bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during granulocyte colony-stimulating factor therapy. Leuk Lymphoma. 1997;26(5\u20136):629\u201332.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"308_CR25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/1097-0142(19910715)68:2<441::AID-CNCR2820680239>3.0.CO;2-4","volume":"68","author":"HJ Ross","year":"1991","unstructured":"Ross HJ, Moy LA, Kaplan R, Figlin RA. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer. 1991;68(2):441\u20133.","journal-title":"Cancer"},{"issue":"5 Suppl","key":"308_CR26","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.jaad.2005.09.017","volume":"55","author":"A Freiman","year":"2006","unstructured":"Freiman A, Brassard A. Pyoderma gangrenosum associated with isotretinoin therapy. J Am Acad Dermatol. 2006;55(5 Suppl):S107\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"308_CR27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2133.1990.tb07291.x","volume":"122","author":"BR Hughes","year":"1990","unstructured":"Hughes BR, Cunliffe WJ. Development of folliculitis and pyoderma gangrenosum in association with abdominal pain in a patient following treatment with isotretinoin. Br J Dermatol. 1990;122(5):683\u20137.","journal-title":"Br J Dermatol"},{"issue":"9","key":"308_CR28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-4632.2008.03662.x","volume":"47","author":"MP Tinoco","year":"2008","unstructured":"Tinoco MP, Tamler C, Maciel G, et al. Pyoderma gangrenosum following isotretinoin therapy for acne nodulocystic. Int J Dermatol. 2008;47(9):953\u20136.","journal-title":"Int J Dermatol"},{"issue":"3","key":"308_CR29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1440-0960.1999.00346.x","volume":"40","author":"T Darben","year":"1999","unstructured":"Darben T, Savige J, Prentice R, et al. Pyoderma gangrenosum with secondary pyarthrosis following propylthiouracil. Australas J Dermatol. 1999;40(3):144\u20136.","journal-title":"Australas J Dermatol"},{"issue":"6","key":"308_CR30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/BF03344152","volume":"29","author":"K Gungor","year":"2006","unstructured":"Gungor K, Gonen S, Kisakol G, et al. ANCA positive propylthiouracil induced pyoderma gangrenosum. J Endocrinol Invest. 2006;29(6):575\u20136.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"308_CR31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000077844","volume":"208","author":"SB Hong","year":"2004","unstructured":"Hong SB, Lee MH. A case of propylthiouracil-induced pyoderma gangrenosum associated with antineutrophil cytoplasmic antibody. Dermatology. 2004;208(4):339\u201341.","journal-title":"Dermatology"},{"issue":"1","key":"308_CR32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5021\/ad.2010.22.1.48","volume":"22","author":"JW Seo","year":"2010","unstructured":"Seo JW, Son HH, Choi JH, et al. A case of p-ANCA-positive propylthiouracil-induced pyoderma gangrenosum. Ann Dermatol. 2010;22(1):48\u201350.","journal-title":"Ann Dermatol"},{"issue":"1","key":"308_CR33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2141.2005.05839.x","volume":"132","author":"FM Miall","year":"2006","unstructured":"Miall FM, Harman K, Kennedy B, Dyer MJ. Pyoderma gangrenosum complicating pegylated granulocyte colony-stimulating factor in Hodgkin lymphoma. Br J Haematol. 2006;132(1):115\u20136.","journal-title":"Br J Haematol"},{"issue":"3","key":"308_CR34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2169\/internalmedicine.37.316","volume":"37","author":"S Takagi","year":"1998","unstructured":"Takagi S, Ohsaka A, Taguchi H, et al. Pyoderma gangrenosum following cytosine arabinoside, aclarubicin and granulocyte colony-stimulating factor combination therapy in myelodysplastic syndrome. Intern Med. 1998;37(3):316\u20139.","journal-title":"Intern Med"},{"issue":"2","key":"308_CR35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1540-9740.2006.04575.x","volume":"5","author":"LE White","year":"2006","unstructured":"White LE, Villa MT, Petronic-Rosic V, et al. Pyoderma gangrenosum related to a new granulocyte colony-stimulating factor. Skinmed. 2006;5(2):96\u20138.","journal-title":"Skinmed."},{"issue":"3","key":"308_CR36","first-page":"98","volume":"6","author":"JM Mir-Bonaf\u00e9","year":"2012","unstructured":"Mir-Bonaf\u00e9 JM, Blanco-Barrios S, Romo-Melgar A, et al. Photoletter to the editor: Localized pyoderma gangrenosum after interferon-alpha2b injections. J Dermatol Case Rep. 2012;6(3):98\u20139.","journal-title":"J Dermatol Case Rep."},{"issue":"1\u20132","key":"308_CR37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10428199809050944","volume":"30","author":"S Montoto","year":"1998","unstructured":"Montoto S, Bosch F, Estrach T, et al. Pyoderma gangrenosum triggered by alpha2b-interferon in a patient with chronic granulocytic leukaemia. Leuk Lymphoma. 1998;30(1\u20132):199\u2013202.","journal-title":"Leuk Lymphoma"},{"key":"308_CR38","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/ndt\/12.7.1506","volume":"12","author":"CW Park","year":"1997","unstructured":"Park CW, Shin YS, Shin MJ, et al. Pyoderma gangrenosum and spinal epidural abscess after subcutaneous administration of recombinant human erythropoietin. Nephrol Dial Transplant. 1997;12:1506\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"308_CR39","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1200\/JCO.2010.32.6165","volume":"29","author":"LD Nadauld","year":"2011","unstructured":"Nadauld LD, Miller MB, Srinivas S. Pyoderma gangrenosum with the use of sunitinib. J Clin Oncol. 2011;29(10):e266\u20137.","journal-title":"J Clin Oncol"},{"issue":"1","key":"308_CR40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2133.2008.08599.x","volume":"159","author":"K Freyhaus ten","year":"2008","unstructured":"ten Freyhaus K, Homey B, Bieber T, Wilsmann-Theis D. Pyoderma gangrenosum: another cutaneous side-effect of sunitinib? Br J Dermatol. 2008;159(1):242\u20133.","journal-title":"Br J Dermatol"},{"issue":"5","key":"308_CR41","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-4632.2011.04952.x","volume":"52","author":"Y Ueharaguchi","year":"2013","unstructured":"Ueharaguchi Y, Kabashima K, Sasahashi M, et al. A case of pyoderma gangrenosum possibly associated with sunitinib treatment. Int J Dermatol. 2013;52(5):634\u20136.","journal-title":"Int J Dermatol"},{"issue":"7","key":"308_CR42","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/jdv.13148","volume":"30","author":"S Usui","year":"2016","unstructured":"Usui S, Otsuka A, Kaku Y, et al. Pyoderma gangrenosum of the penis possibly associated with pazopanib treatment. J Eur Acad Dermatol Venereol. 2016;30(7):1222\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"308_CR43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3315\/jdcr.2009.1027","volume":"3","author":"N Jaimes-L\u00f3pez","year":"2009","unstructured":"Jaimes-L\u00f3pez N, Molina V, Arroyave JE, et al. Developement of pyoderma gangraenosum during therapy with infliximab. J Dermatol Case Rep. 2009;3:20\u20133.","journal-title":"J Dermatol Case Rep"},{"issue":"12","key":"308_CR44","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s10067-007-0733-8","volume":"26","author":"K Vandevyvere","year":"2007","unstructured":"Vandevyvere K, Luyten FP, Verschueren P, et al. Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis. Clin Rheumatol. 2007;26(12):2205\u20136.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"308_CR45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1684\/ejd.2015.2526","volume":"25","author":"M Vestita","year":"2015","unstructured":"Vestita M, Guida S, Mazzoccoli S, et al. Late paradoxical development of pyoderma gangrenosum in a psoriasis patient treated with infliximab. Eur J Dermatol. 2015;25(3):272\u20133.","journal-title":"Eur J Dermatol."},{"key":"308_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12498","author":"C Baliu-Piqu\u00e9","year":"2016","unstructured":"Baliu-Piqu\u00e9 C, Mascar\u00f3 JM Jr. Multifocal and refractory pyoderma gangrenosum: possible role of cocaine abuse. Australas J Dermatol. 2016. doi: 10.1111\/ajd.12498 .","journal-title":"Australas J Dermatol."},{"issue":"5","key":"308_CR47","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaad.2015.11.040","volume":"74","author":"HS Jeong","year":"2016","unstructured":"Jeong HS, Layher H, Cao L, et al. Pyoderma gangrenosum (PG) associated with levamisole-adulterated cocaine: clinical, serologic, and histopathologic findings in a cohort of patients. J Am Acad Dermatol. 2016;74(5):892\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"308_CR48","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/ijd.12212","volume":"54","author":"PJ Keith","year":"2015","unstructured":"Keith PJ, Joyce JC, Wilson BD. Pyoderma gangrenosum: a possible cutaneous complication of levamisole-tainted cocaine abuse. Int J Dermatol. 2015;54(9):1075\u20137.","journal-title":"Int J Dermatol"},{"issue":"4","key":"308_CR49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/bjh.13341","volume":"169","author":"E Tseng","year":"2015","unstructured":"Tseng E, Alhusayen R, Sade S, et al. Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome. Br J Haematol. 2015;169(4):461.","journal-title":"Br J Haematol"},{"issue":"2","key":"308_CR50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/2229-5178.86010","volume":"2","author":"M Kumaresan","year":"2011","unstructured":"Kumaresan M, Rai R, Sekar S, Natarajan K. Ciprofloxacin induced pyoderma gangrenosum. Indian Dermatol Online J. 2011;2(2):122\u20134.","journal-title":"Indian Dermatol Online J."},{"issue":"2","key":"308_CR51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1684\/ejd.2014.2297","volume":"24","author":"BM Rudolph","year":"2014","unstructured":"Rudolph BM, Staib F, Von Stebut E, et al. Neutrophilic disease of the skin and intestines after ipilimumab treatment for malignant melanoma\u2014simultaneous occurrence of pyoderma gangrenosum and colitis. Eur J Dermatol. 2014;24(2):268\u20139.","journal-title":"Eur J Dermatol."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-017-0308-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0308-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0308-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T05:52:18Z","timestamp":1602309138000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-017-0308-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,17]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["308"],"URL":"https:\/\/doi.org\/10.1007\/s40257-017-0308-7","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,17]]}}}